Enrique Girona‐Llobera

Evidence of meaningful levels of <i>Trypanosoma cruzi</i> in platelet concentrates from seropositive blood donors

Beatriz Cancino‐Faure, Roser Fisa, Cristina Riera et al. · Transfusion · 2015 · 34 citations · Full text

Medicine, Hematology, Infectious Diseases +17

Reducing the financial impact of pathogen inactivation technology for platelet components: our experience

Enrique Girona‐Llobera, Teresa Jimenéz‐Marco, Ana Galmes‐Trueba et al. · Transfusion · 2013 · 33 citations

Medicine, Hematology, Pharmacoeconomics +16

Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach.

Teresa Jimenéz‐Marco, Cristina Riera, Enrique Girona‐Llobera et al. · PubMed · 2018 · 20 citations · Full text

Medicine, Hematology, Infectious Diseases +17

The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating <i>Trypanosoma cruzi</i> from leukoreduced whole blood

Teresa Jimenéz‐Marco, Beatriz Cancino‐Faure, Enrique Girona‐Llobera et al. · Transfusion · 2017 · 15 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient care

Teresa Jimenéz‐Marco, Marta García‐Recio, Enrique Girona‐Llobera · Transfusion · 2018 · 15 citations · Full text

Medicine, Hematology, Cost-minimization Analysis +16